我斗神的个人主页 - 老虎社区

我斗神

暂无个人介绍

IP属地：广东

24关注

0粉丝

0主题

0勋章

2019-11-28

$阿里巴巴-SW(09988)$ 真是让人意外

2021-01-01

无关紧要，又不是只有一个app平台

华为平台全面下架腾讯游戏！

2021-02-17

苏踏踏听！TV58 是

DEADLINE: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against Clover Health Investments, Corp. – CLOV, CLOVW, IPOC

2021-02-17

84

DEADLINE: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against Clover Health Investments, Corp. – CLOV, CLOVW, IPOC

2019-11-25

中了一手

阿里巴巴：香港IPO面向散户部分获得42.4倍认购

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3489705817352597","uuid":"3489705817352597","gmtCreate":1526613340301,"gmtModify":1526613340301,"name":"我斗神","pinyin":"wdswodoushen","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":24,"tweetSize":5,"questionSize":0,"limitLevel":900,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-4","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"明星虎友","description":"加入老虎社区2000天","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","grayImgUrl":"https://static.tigerbbs.com/6304700d92ad91c7a33e2e92ec32ecc1","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.11.08","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"228c86a078844d74991fff2b7ab2428d-1","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资经理虎","description":"证券账户累计交易金额达到10万美元","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"60.42%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"60.55%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"广东","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":385259518,"gmtCreate":1613557222334,"gmtModify":1613557222334,"author":{"id":"3489705817352597","authorId":"3489705817352597","name":"我斗神","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3489705817352597","authorIdStr":"3489705817352597"},"themes":[],"htmlText":"苏踏踏 听！TV58&nbsp; 是&nbsp;","listText":"苏踏踏 听！TV58&nbsp; 是&nbsp;","text":"苏踏踏 听！TV58 是","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/385259518","repostId":"2112882414","repostType":2,"repost":{"id":"2112882414","pubTimestamp":1613494980,"share":"https://www.laohu8.com/m/news/2112882414?lang=&edition=full","pubTime":"2021-02-17 01:03","market":"us","language":"zh","title":"DEADLINE: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against  Clover Health Investments, Corp. – CLOV, CLOVW, IPOC","url":"https://stock-news.laohu8.com/highlight/detail?id=2112882414","media":"GlobeNewswire","summary":"NEW YORK, Feb. 17, 2021  -- Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Clover Health Investments, Corp. f/k/a Social Capital Hedosophia Holdings Corp. III   who:  purchased or otherwise acquired publicly traded Clover securities between October 6, 2020 and February 4, 2021, inclusive ; and/or  purchased or otherwise acquired Clover securities pursuant or traceable to the registration statement and prospectus issued in connection with the December 2020 Merger of Clover and Social Capital III.If you wish to serve as lead plaintiff, you must move the Court before the April 6, 2021 DEADLINE. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.Zhang Investor Law represents investors worldwide. Attorney Advertising. Prior results do not guarantee similar outcomes.","content":"<html><body><p>NEW YORK, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of  Clover Health Investments, Corp. f/k/a <a href=\"https://laohu8.com/S/IPOC.U\">Social Capital Hedosophia Holdings Corp. III</a> (NASDAQ: CLOV, CLOVW) (NYSE: IPOC) who: (1) purchased or otherwise acquired publicly traded Clover securities between October 6, 2020 and February 4, 2021, inclusive (the “Class Period”); and/or (2) purchased or otherwise acquired Clover securities pursuant or traceable to the registration statement and prospectus issued in connection with the December 2020 Merger of Clover and Social Capital III.<br/></p>\n<p>To join the class action, go to http://zhanginvestorlaw.com/join-action-form/?slug=clover-health-investments-corp&amp;id=2582 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email info@zhanginvestorlaw.com for information on the class action.</p>\n<p>如果您想加入这个集体诉讼案，请在这里提交您的信息。http://zhanginvestorlaw.com/join-action-form/?slug=clover-health-investments-corp&amp;id=2582</p>\n<p>If you wish to serve as lead plaintiff, you must move the Court before the <strong>April 6, 2021 DEADLINE.</strong>   A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. </p>\n<p>According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that-    Clover’s was under active investigation by the Department of Justice for at least 12 issues ranging from kickbacks to marketing practices to undisclosed third-party deals; the DOJ’s investigation presented an existential risk to the Company, since it derives most of its revenues from Medicare; Clover’s sales were driven by a major undisclosed related party deal and misleading marketing targeting the elderly, not its purported “best-in-class” technology; a significant portion of Clover sales were by way of an undisclosed relationship between Clover and an outside brokerage firm controlled by Clover’s Head of Sales; and as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.</p>\n<p>Lead plaintiff status is not required to seek compensation.  You may retain counsel of your choice.  You may remain an absent class member and take no action at this time.</p>\n<p>Zhang Investor Law represents investors worldwide. Attorney Advertising. Prior results do not guarantee similar outcomes.</p>\n<p>Zhang Investor Law P.C.<br/>99 Wall Street, Suite 232<br/>New York, New York 10005<br/>info@zhanginvestorlaw.com<br/>tel: (800) 991-3756<br/></p>\n<br/>\n<img height=\"1\" src=\"https://ml.globenewswire.com/release/track/397ce691-d08f-4fd4-bcbf-4dbc163b6780\" width=\"1\"/></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>DEADLINE: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against  Clover Health Investments, Corp. – CLOV, CLOVW, IPOC</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDEADLINE: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against  Clover Health Investments, Corp. – CLOV, CLOVW, IPOC\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-17 01:03 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/deadline-zhang-investor-law-alerts-170300583.html><strong>GlobeNewswire</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>NEW YORK, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of  Clover Health Investments, Corp. f/k/a Social Capital ...</p>\n\n<a href=\"https://finance.yahoo.com/news/deadline-zhang-investor-law-alerts-170300583.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://s.yimg.com/uu/api/res/1.2/9ZrC1RTINuwAePNbhMocgQ--~B/aD0xMjU7dz03NzU7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/vWhXIXoqEFvlQel1Gatm7Q--~B/aD0xMjU7dz03NzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/e259ec0cd2e22aa5c7cb38ac472d47ba","relate_stocks":{"CLOVW":"Clover Health Corp Warrant 2025/04/21 11.5C","CLOV":"Clover Health Corp"},"source_url":"https://finance.yahoo.com/news/deadline-zhang-investor-law-alerts-170300583.html","is_english":false,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2112882414","content_text":"NEW YORK, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of  Clover Health Investments, Corp. f/k/a Social Capital Hedosophia Holdings Corp. III (NASDAQ: CLOV, CLOVW) (NYSE: IPOC) who: (1) purchased or otherwise acquired publicly traded Clover securities between October 6, 2020 and February 4, 2021, inclusive (the “Class Period”); and/or (2) purchased or otherwise acquired Clover securities pursuant or traceable to the registration statement and prospectus issued in connection with the December 2020 Merger of Clover and Social Capital III.\nTo join the class action, go to http://zhanginvestorlaw.com/join-action-form/?slug=clover-health-investments-corp&id=2582 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email info@zhanginvestorlaw.com for information on the class action.\n如果您想加入这个集体诉讼案，请在这里提交您的信息。http://zhanginvestorlaw.com/join-action-form/?slug=clover-health-investments-corp&id=2582\nIf you wish to serve as lead plaintiff, you must move the Court before the April 6, 2021 DEADLINE.   A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. \nAccording to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that-    Clover’s was under active investigation by the Department of Justice for at least 12 issues ranging from kickbacks to marketing practices to undisclosed third-party deals; the DOJ’s investigation presented an existential risk to the Company, since it derives most of its revenues from Medicare; Clover’s sales were driven by a major undisclosed related party deal and misleading marketing targeting the elderly, not its purported “best-in-class” technology; a significant portion of Clover sales were by way of an undisclosed relationship between Clover and an outside brokerage firm controlled by Clover’s Head of Sales; and as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.\nLead plaintiff status is not required to seek compensation.  You may retain counsel of your choice.  You may remain an absent class member and take no action at this time.\nZhang Investor Law represents investors worldwide. Attorney Advertising. Prior results do not guarantee similar outcomes.\nZhang Investor Law P.C.99 Wall Street, Suite 232New York, New York 10005info@zhanginvestorlaw.comtel: (800) 991-3756","news_type":1},"isVote":1,"tweetType":1,"viewCount":1592,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":385259811,"gmtCreate":1613557169833,"gmtModify":1613557169833,"author":{"id":"3489705817352597","authorId":"3489705817352597","name":"我斗神","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3489705817352597","authorIdStr":"3489705817352597"},"themes":[],"htmlText":"84","listText":"84","text":"84","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/385259811","repostId":"2112882414","repostType":2,"repost":{"id":"2112882414","pubTimestamp":1613494980,"share":"https://www.laohu8.com/m/news/2112882414?lang=&edition=full","pubTime":"2021-02-17 01:03","market":"us","language":"zh","title":"DEADLINE: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against  Clover Health Investments, Corp. – CLOV, CLOVW, IPOC","url":"https://stock-news.laohu8.com/highlight/detail?id=2112882414","media":"GlobeNewswire","summary":"NEW YORK, Feb. 17, 2021  -- Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Clover Health Investments, Corp. f/k/a Social Capital Hedosophia Holdings Corp. III   who:  purchased or otherwise acquired publicly traded Clover securities between October 6, 2020 and February 4, 2021, inclusive ; and/or  purchased or otherwise acquired Clover securities pursuant or traceable to the registration statement and prospectus issued in connection with the December 2020 Merger of Clover and Social Capital III.If you wish to serve as lead plaintiff, you must move the Court before the April 6, 2021 DEADLINE. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.Zhang Investor Law represents investors worldwide. Attorney Advertising. Prior results do not guarantee similar outcomes.","content":"<html><body><p>NEW YORK, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of  Clover Health Investments, Corp. f/k/a <a href=\"https://laohu8.com/S/IPOC.U\">Social Capital Hedosophia Holdings Corp. III</a> (NASDAQ: CLOV, CLOVW) (NYSE: IPOC) who: (1) purchased or otherwise acquired publicly traded Clover securities between October 6, 2020 and February 4, 2021, inclusive (the “Class Period”); and/or (2) purchased or otherwise acquired Clover securities pursuant or traceable to the registration statement and prospectus issued in connection with the December 2020 Merger of Clover and Social Capital III.<br/></p>\n<p>To join the class action, go to http://zhanginvestorlaw.com/join-action-form/?slug=clover-health-investments-corp&amp;id=2582 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email info@zhanginvestorlaw.com for information on the class action.</p>\n<p>如果您想加入这个集体诉讼案，请在这里提交您的信息。http://zhanginvestorlaw.com/join-action-form/?slug=clover-health-investments-corp&amp;id=2582</p>\n<p>If you wish to serve as lead plaintiff, you must move the Court before the <strong>April 6, 2021 DEADLINE.</strong>   A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. </p>\n<p>According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that-    Clover’s was under active investigation by the Department of Justice for at least 12 issues ranging from kickbacks to marketing practices to undisclosed third-party deals; the DOJ’s investigation presented an existential risk to the Company, since it derives most of its revenues from Medicare; Clover’s sales were driven by a major undisclosed related party deal and misleading marketing targeting the elderly, not its purported “best-in-class” technology; a significant portion of Clover sales were by way of an undisclosed relationship between Clover and an outside brokerage firm controlled by Clover’s Head of Sales; and as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.</p>\n<p>Lead plaintiff status is not required to seek compensation.  You may retain counsel of your choice.  You may remain an absent class member and take no action at this time.</p>\n<p>Zhang Investor Law represents investors worldwide. Attorney Advertising. Prior results do not guarantee similar outcomes.</p>\n<p>Zhang Investor Law P.C.<br/>99 Wall Street, Suite 232<br/>New York, New York 10005<br/>info@zhanginvestorlaw.com<br/>tel: (800) 991-3756<br/></p>\n<br/>\n<img height=\"1\" src=\"https://ml.globenewswire.com/release/track/397ce691-d08f-4fd4-bcbf-4dbc163b6780\" width=\"1\"/></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>DEADLINE: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against  Clover Health Investments, Corp. – CLOV, CLOVW, IPOC</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDEADLINE: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against  Clover Health Investments, Corp. – CLOV, CLOVW, IPOC\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-17 01:03 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/deadline-zhang-investor-law-alerts-170300583.html><strong>GlobeNewswire</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>NEW YORK, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of  Clover Health Investments, Corp. f/k/a Social Capital ...</p>\n\n<a href=\"https://finance.yahoo.com/news/deadline-zhang-investor-law-alerts-170300583.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://s.yimg.com/uu/api/res/1.2/9ZrC1RTINuwAePNbhMocgQ--~B/aD0xMjU7dz03NzU7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/vWhXIXoqEFvlQel1Gatm7Q--~B/aD0xMjU7dz03NzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/e259ec0cd2e22aa5c7cb38ac472d47ba","relate_stocks":{"CLOVW":"Clover Health Corp Warrant 2025/04/21 11.5C","CLOV":"Clover Health Corp"},"source_url":"https://finance.yahoo.com/news/deadline-zhang-investor-law-alerts-170300583.html","is_english":false,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2112882414","content_text":"NEW YORK, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of  Clover Health Investments, Corp. f/k/a Social Capital Hedosophia Holdings Corp. III (NASDAQ: CLOV, CLOVW) (NYSE: IPOC) who: (1) purchased or otherwise acquired publicly traded Clover securities between October 6, 2020 and February 4, 2021, inclusive (the “Class Period”); and/or (2) purchased or otherwise acquired Clover securities pursuant or traceable to the registration statement and prospectus issued in connection with the December 2020 Merger of Clover and Social Capital III.\nTo join the class action, go to http://zhanginvestorlaw.com/join-action-form/?slug=clover-health-investments-corp&id=2582 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email info@zhanginvestorlaw.com for information on the class action.\n如果您想加入这个集体诉讼案，请在这里提交您的信息。http://zhanginvestorlaw.com/join-action-form/?slug=clover-health-investments-corp&id=2582\nIf you wish to serve as lead plaintiff, you must move the Court before the April 6, 2021 DEADLINE.   A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. \nAccording to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that-    Clover’s was under active investigation by the Department of Justice for at least 12 issues ranging from kickbacks to marketing practices to undisclosed third-party deals; the DOJ’s investigation presented an existential risk to the Company, since it derives most of its revenues from Medicare; Clover’s sales were driven by a major undisclosed related party deal and misleading marketing targeting the elderly, not its purported “best-in-class” technology; a significant portion of Clover sales were by way of an undisclosed relationship between Clover and an outside brokerage firm controlled by Clover’s Head of Sales; and as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.\nLead plaintiff status is not required to seek compensation.  You may retain counsel of your choice.  You may remain an absent class member and take no action at this time.\nZhang Investor Law represents investors worldwide. Attorney Advertising. Prior results do not guarantee similar outcomes.\nZhang Investor Law P.C.99 Wall Street, Suite 232New York, New York 10005info@zhanginvestorlaw.comtel: (800) 991-3756","news_type":1},"isVote":1,"tweetType":1,"viewCount":418,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":331166723,"gmtCreate":1609467961062,"gmtModify":1703739575689,"author":{"id":"3489705817352597","authorId":"3489705817352597","name":"我斗神","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3489705817352597","authorIdStr":"3489705817352597"},"themes":[],"htmlText":"无关紧要，又不是只有一个app平台","listText":"无关紧要，又不是只有一个app平台","text":"无关紧要，又不是只有一个app平台","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/331166723","repostId":"1176920029","repostType":4,"repost":{"id":"1176920029","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1609467812,"share":"https://www.laohu8.com/m/news/1176920029?lang=&edition=full","pubTime":"2021-01-01 10:23","market":"us","language":"zh","title":"华为平台全面下架腾讯游戏！","url":"https://stock-news.laohu8.com/highlight/detail?id=1176920029","media":"老虎资讯综合","summary":"1日讯，华为游戏中心社区发布公告：因腾讯游戏于2020年12月31日17点57分单方面就双方合作做出重大变更，导致双方的继续合作产生重大障碍，经过我司法务谨慎评估，我们不得不依照腾讯单方面要求暂停相关","content":"<p>1日讯，华为游戏中心社区发布公告：因腾讯游戏于2020年12月31日17点57分单方面就双方合作做出重大变更，导致双方的继续合作产生重大障碍，经过我司法务谨慎评估，我们不得不依照腾讯单方面要求暂停相关合作，将腾讯游戏从华为平台下架。</p><p><img src=\"https://static.tigerbbs.com/11ce88109a0a947e895dab4a91f4905d\" tg-width=\"474\" tg-height=\"576\"></p><p>腾讯游戏方面回应称，因华为手机游戏平台与我们的《手机游戏推广项目协议》未能如期续约，导致今天凌晨腾讯游戏的相关产品被突然下架。目前我们正积极与华为手机游戏平台沟通协商，争取尽快恢复。给各位用户带来的不便，我们深表歉意。</p><p>据第一财经报道，一知情人士表示，<b>事件的导火索在于分成比例没有谈拢</b>。</p><p>过去，游戏行业一直处于粗放发展的时期，也是渠道为王的时期。手机官方应用商店组成的硬核联盟，和游戏发行商分成比例一直是五五。而在国外，苹果App Store和安卓Google Play和发行商的分成比例是三七。</p><p>但随着市场环境的变化，用户触达游戏的渠道呈多元化趋势。传统货架式游戏分发渠道已经逐渐式微，年轻一代玩家逐渐通过游戏社区论坛、公众号、图文内容平台或周边口碑转播等接触和认知一款游戏，货架式游戏应用中心不再是玩家下载游戏的唯一通道，渠道也在变革的过程中。</p><p>从2019年年中开始，腾讯对渠道商提出了新的分成比例，旗下新游戏的流水渠道和开发以三七比例来分成，即应用市场拿三成，开发商等拿七成。</p><p>&nbsp;一不愿具名的手机厂商内部人士表示，腾讯方面就分成的问题这两年一直在与厂商进行谈判，但目前中国渠道市场较海外更加复杂，不能简单的说成是分成比例问题，也不能照搬海外分成模式。</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>华为平台全面下架腾讯游戏！</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n华为平台全面下架腾讯游戏！\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2021-01-01 10:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>1日讯，华为游戏中心社区发布公告：因腾讯游戏于2020年12月31日17点57分单方面就双方合作做出重大变更，导致双方的继续合作产生重大障碍，经过我司法务谨慎评估，我们不得不依照腾讯单方面要求暂停相关合作，将腾讯游戏从华为平台下架。</p><p><img src=\"https://static.tigerbbs.com/11ce88109a0a947e895dab4a91f4905d\" tg-width=\"474\" tg-height=\"576\"></p><p>腾讯游戏方面回应称，因华为手机游戏平台与我们的《手机游戏推广项目协议》未能如期续约，导致今天凌晨腾讯游戏的相关产品被突然下架。目前我们正积极与华为手机游戏平台沟通协商，争取尽快恢复。给各位用户带来的不便，我们深表歉意。</p><p>据第一财经报道，一知情人士表示，<b>事件的导火索在于分成比例没有谈拢</b>。</p><p>过去，游戏行业一直处于粗放发展的时期，也是渠道为王的时期。手机官方应用商店组成的硬核联盟，和游戏发行商分成比例一直是五五。而在国外，苹果App Store和安卓Google Play和发行商的分成比例是三七。</p><p>但随着市场环境的变化，用户触达游戏的渠道呈多元化趋势。传统货架式游戏分发渠道已经逐渐式微，年轻一代玩家逐渐通过游戏社区论坛、公众号、图文内容平台或周边口碑转播等接触和认知一款游戏，货架式游戏应用中心不再是玩家下载游戏的唯一通道，渠道也在变革的过程中。</p><p>从2019年年中开始，腾讯对渠道商提出了新的分成比例，旗下新游戏的流水渠道和开发以三七比例来分成，即应用市场拿三成，开发商等拿七成。</p><p>&nbsp;一不愿具名的手机厂商内部人士表示，腾讯方面就分成的问题这两年一直在与厂商进行谈判，但目前中国渠道市场较海外更加复杂，不能简单的说成是分成比例问题，也不能照搬海外分成模式。</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/ce88d7c500914d5edde5f4ccbc6959f5","relate_stocks":{"00700":"腾讯控股"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1176920029","content_text":"1日讯，华为游戏中心社区发布公告：因腾讯游戏于2020年12月31日17点57分单方面就双方合作做出重大变更，导致双方的继续合作产生重大障碍，经过我司法务谨慎评估，我们不得不依照腾讯单方面要求暂停相关合作，将腾讯游戏从华为平台下架。腾讯游戏方面回应称，因华为手机游戏平台与我们的《手机游戏推广项目协议》未能如期续约，导致今天凌晨腾讯游戏的相关产品被突然下架。目前我们正积极与华为手机游戏平台沟通协商，争取尽快恢复。给各位用户带来的不便，我们深表歉意。据第一财经报道，一知情人士表示，事件的导火索在于分成比例没有谈拢。过去，游戏行业一直处于粗放发展的时期，也是渠道为王的时期。手机官方应用商店组成的硬核联盟，和游戏发行商分成比例一直是五五。而在国外，苹果App Store和安卓Google Play和发行商的分成比例是三七。但随着市场环境的变化，用户触达游戏的渠道呈多元化趋势。传统货架式游戏分发渠道已经逐渐式微，年轻一代玩家逐渐通过游戏社区论坛、公众号、图文内容平台或周边口碑转播等接触和认知一款游戏，货架式游戏应用中心不再是玩家下载游戏的唯一通道，渠道也在变革的过程中。从2019年年中开始，腾讯对渠道商提出了新的分成比例，旗下新游戏的流水渠道和开发以三七比例来分成，即应用市场拿三成，开发商等拿七成。 一不愿具名的手机厂商内部人士表示，腾讯方面就分成的问题这两年一直在与厂商进行谈判，但目前中国渠道市场较海外更加复杂，不能简单的说成是分成比例问题，也不能照搬海外分成模式。","news_type":1},"isVote":1,"tweetType":1,"viewCount":1196,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":937680554,"gmtCreate":1574926508078,"gmtModify":1704728841628,"author":{"id":"3489705817352597","authorId":"3489705817352597","name":"我斗神","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3489705817352597","authorIdStr":"3489705817352597"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/09988\">$阿里巴巴-SW(09988)$</a>&nbsp;真是让人意外","listText":"<a href=\"https://laohu8.com/S/09988\">$阿里巴巴-SW(09988)$</a>&nbsp;真是让人意外","text":"$阿里巴巴-SW(09988)$ 真是让人意外","images":[{"img":"https://static.tigerbbs.com/8c22f24c7a1047a48ecd5aed0b368dcc","width":"1080","height":"1718"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/937680554","isVote":1,"tweetType":1,"viewCount":1661,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":937051413,"gmtCreate":1574671030632,"gmtModify":1704728233941,"author":{"id":"3489705817352597","authorId":"3489705817352597","name":"我斗神","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3489705817352597","authorIdStr":"3489705817352597"},"themes":[],"htmlText":"中了一手","listText":"中了一手","text":"中了一手","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/937051413","repostId":"1160045784","repostType":4,"repost":{"id":"1160045784","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1574641000,"share":"https://www.laohu8.com/m/news/1160045784?lang=&edition=full","pubTime":"2019-11-25 08:16","market":"us","language":"zh","title":"阿里巴巴：香港IPO面向散户部分获得42.4倍认购","url":"https://stock-news.laohu8.com/highlight/detail?id=1160045784","media":"老虎资讯综合","summary":"据港媒报道，阿里巴巴（$(09988)$）成为港股史上集资额第三大新股。阿里昨天公布，以每股176元定价，较周二（19日）阿里ADS（美国存託股票）收市价折让2.8%，集资880亿元；在悉数行使超额配","content":"<p><img src=\"https://static.tigerbbs.com/626ae71536f62fb9c7fdbe50fbdbb2c7\">据港媒报道，阿里巴巴（<a href=\"https://laohu8.com/S/09988\">$(09988)$</a>）成为港股史上集资额第三大新股。阿里昨天公布，以每股176元定价，较周二（19日）阿里ADS（美国存託股票）收市价折让2.8%，集资880亿元；在悉数行使超额配售权后，总集资额将达1012亿元。据悉，阿里公开发售录得逾40倍超购，冻资约963亿元，问鼎今年新股冻资王。</p>\n<p><b>集资1012亿 史上第三重磅</b></p>\n<p>此外，港交所（<a href=\"https://laohu8.com/S/00388\">$(00388)$</a>）将推出阿里期货及期权，并批准发行商推出相关窝轮，与正股同于下周二挂牌，上市当日即纳入认可卖空指定证券名单。</p>\n<p>阿里原定发行5亿股，其中公开发售佔2.5%，国际配售佔97.5%，并设7500万股超额配售权，由瑞信及中金担任联席保荐人。由于公开发售超购逾40倍，将启动回拨机制，令公开发售股份佔比由2.5%增加至10%。据了解，国际配售部分获得主权基金及长仓基金等支持，亦录数倍超购。</p>\n<p>阿里表示，今次定价176元，是综合了ADS在周二收市价等因素釐定，相当于每份阿里ADS约180美元，较周二收市价185.25美元折让约2.8%，较公开发售价上限188元则低6.38%。路透报道，阿里已悉数行使超额配售权，集资额增至1012亿元，成为港股史上集资额第三大新股，仅次于2010年集资1590亿元的友邦（01299），以及2006年集资1249.5亿元的工行（01398），是9年来本港最大型IPO。阿里ADS收报182.35美元，跌1.57%。</p>\n<p><b>较ADS折让2.8% 反应胜预期</b></p>\n<p>辉立证券企业融资经理陈英杰表示，最终定价较阿里ADS有2.8%折让，亦低于公开发售价上限188元，加上公开发售反应热烈，超购远胜他预期的约10倍，算是意外惊喜；阿里下周二挂牌前，阿里ADS仍然有潜在下跌风险，挂牌当日有可能出现跟跌。不过，该行客户大部分表明会长揸，相信影响不大。</p>\n<p>有基金经理笑言，本身认购阿里不多，长远亦看好内地电商发展，尽管有折扣也仅属锦上添花，他反而最关注阿里最终能否获纳入恒指成分股及「港股通」。</p>\n<p>恒指公司最快今年底才会公布恒指纳入同股不同权（W股）股份的咨询文件，并一并处理第二上市的W股纳入相关指数；至于阿里能否快速晋身恒生综合指数，则由于阿里是首只第二上市的W股，恒指公司正研究使用合适方法去厘定阿里的「市值」，届时方知是否符合要求。</p>\n<p>港交所日前指出，现时第二上市的不同投票权架构公司，暂不纳入「港股通」股票范围，意味阿里短期内与北水无缘。</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>阿里巴巴：香港IPO面向散户部分获得42.4倍认购</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n阿里巴巴：香港IPO面向散户部分获得42.4倍认购\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2019-11-25 08:16</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><img src=\"https://static.tigerbbs.com/626ae71536f62fb9c7fdbe50fbdbb2c7\">据港媒报道，阿里巴巴（<a href=\"https://laohu8.com/S/09988\">$(09988)$</a>）成为港股史上集资额第三大新股。阿里昨天公布，以每股176元定价，较周二（19日）阿里ADS（美国存託股票）收市价折让2.8%，集资880亿元；在悉数行使超额配售权后，总集资额将达1012亿元。据悉，阿里公开发售录得逾40倍超购，冻资约963亿元，问鼎今年新股冻资王。</p>\n<p><b>集资1012亿 史上第三重磅</b></p>\n<p>此外，港交所（<a href=\"https://laohu8.com/S/00388\">$(00388)$</a>）将推出阿里期货及期权，并批准发行商推出相关窝轮，与正股同于下周二挂牌，上市当日即纳入认可卖空指定证券名单。</p>\n<p>阿里原定发行5亿股，其中公开发售佔2.5%，国际配售佔97.5%，并设7500万股超额配售权，由瑞信及中金担任联席保荐人。由于公开发售超购逾40倍，将启动回拨机制，令公开发售股份佔比由2.5%增加至10%。据了解，国际配售部分获得主权基金及长仓基金等支持，亦录数倍超购。</p>\n<p>阿里表示，今次定价176元，是综合了ADS在周二收市价等因素釐定，相当于每份阿里ADS约180美元，较周二收市价185.25美元折让约2.8%，较公开发售价上限188元则低6.38%。路透报道，阿里已悉数行使超额配售权，集资额增至1012亿元，成为港股史上集资额第三大新股，仅次于2010年集资1590亿元的友邦（01299），以及2006年集资1249.5亿元的工行（01398），是9年来本港最大型IPO。阿里ADS收报182.35美元，跌1.57%。</p>\n<p><b>较ADS折让2.8% 反应胜预期</b></p>\n<p>辉立证券企业融资经理陈英杰表示，最终定价较阿里ADS有2.8%折让，亦低于公开发售价上限188元，加上公开发售反应热烈，超购远胜他预期的约10倍，算是意外惊喜；阿里下周二挂牌前，阿里ADS仍然有潜在下跌风险，挂牌当日有可能出现跟跌。不过，该行客户大部分表明会长揸，相信影响不大。</p>\n<p>有基金经理笑言，本身认购阿里不多，长远亦看好内地电商发展，尽管有折扣也仅属锦上添花，他反而最关注阿里最终能否获纳入恒指成分股及「港股通」。</p>\n<p>恒指公司最快今年底才会公布恒指纳入同股不同权（W股）股份的咨询文件，并一并处理第二上市的W股纳入相关指数；至于阿里能否快速晋身恒生综合指数，则由于阿里是首只第二上市的W股，恒指公司正研究使用合适方法去厘定阿里的「市值」，届时方知是否符合要求。</p>\n<p>港交所日前指出，现时第二上市的不同投票权架构公司，暂不纳入「港股通」股票范围，意味阿里短期内与北水无缘。</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/f98a08f234fb3dfe04b5578614dea292","relate_stocks":{},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1160045784","content_text":"据港媒报道，阿里巴巴（$(09988)$）成为港股史上集资额第三大新股。阿里昨天公布，以每股176元定价，较周二（19日）阿里ADS（美国存託股票）收市价折让2.8%，集资880亿元；在悉数行使超额配售权后，总集资额将达1012亿元。据悉，阿里公开发售录得逾40倍超购，冻资约963亿元，问鼎今年新股冻资王。\n集资1012亿 史上第三重磅\n此外，港交所（$(00388)$）将推出阿里期货及期权，并批准发行商推出相关窝轮，与正股同于下周二挂牌，上市当日即纳入认可卖空指定证券名单。\n阿里原定发行5亿股，其中公开发售佔2.5%，国际配售佔97.5%，并设7500万股超额配售权，由瑞信及中金担任联席保荐人。由于公开发售超购逾40倍，将启动回拨机制，令公开发售股份佔比由2.5%增加至10%。据了解，国际配售部分获得主权基金及长仓基金等支持，亦录数倍超购。\n阿里表示，今次定价176元，是综合了ADS在周二收市价等因素釐定，相当于每份阿里ADS约180美元，较周二收市价185.25美元折让约2.8%，较公开发售价上限188元则低6.38%。路透报道，阿里已悉数行使超额配售权，集资额增至1012亿元，成为港股史上集资额第三大新股，仅次于2010年集资1590亿元的友邦（01299），以及2006年集资1249.5亿元的工行（01398），是9年来本港最大型IPO。阿里ADS收报182.35美元，跌1.57%。\n较ADS折让2.8% 反应胜预期\n辉立证券企业融资经理陈英杰表示，最终定价较阿里ADS有2.8%折让，亦低于公开发售价上限188元，加上公开发售反应热烈，超购远胜他预期的约10倍，算是意外惊喜；阿里下周二挂牌前，阿里ADS仍然有潜在下跌风险，挂牌当日有可能出现跟跌。不过，该行客户大部分表明会长揸，相信影响不大。\n有基金经理笑言，本身认购阿里不多，长远亦看好内地电商发展，尽管有折扣也仅属锦上添花，他反而最关注阿里最终能否获纳入恒指成分股及「港股通」。\n恒指公司最快今年底才会公布恒指纳入同股不同权（W股）股份的咨询文件，并一并处理第二上市的W股纳入相关指数；至于阿里能否快速晋身恒生综合指数，则由于阿里是首只第二上市的W股，恒指公司正研究使用合适方法去厘定阿里的「市值」，届时方知是否符合要求。\n港交所日前指出，现时第二上市的不同投票权架构公司，暂不纳入「港股通」股票范围，意味阿里短期内与北水无缘。","news_type":1},"isVote":1,"tweetType":1,"viewCount":1459,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":937680554,"gmtCreate":1574926508078,"gmtModify":1704728841628,"author":{"id":"3489705817352597","authorId":"3489705817352597","name":"我斗神","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3489705817352597","authorIdStr":"3489705817352597"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/09988\">$阿里巴巴-SW(09988)$</a>&nbsp;真是让人意外","listText":"<a href=\"https://laohu8.com/S/09988\">$阿里巴巴-SW(09988)$</a>&nbsp;真是让人意外","text":"$阿里巴巴-SW(09988)$ 真是让人意外","images":[{"img":"https://static.tigerbbs.com/8c22f24c7a1047a48ecd5aed0b368dcc","width":"1080","height":"1718"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/937680554","isVote":1,"tweetType":1,"viewCount":1661,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":331166723,"gmtCreate":1609467961062,"gmtModify":1703739575689,"author":{"id":"3489705817352597","authorId":"3489705817352597","name":"我斗神","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3489705817352597","authorIdStr":"3489705817352597"},"themes":[],"htmlText":"无关紧要，又不是只有一个app平台","listText":"无关紧要，又不是只有一个app平台","text":"无关紧要，又不是只有一个app平台","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/331166723","repostId":"1176920029","repostType":4,"repost":{"id":"1176920029","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1609467812,"share":"https://www.laohu8.com/m/news/1176920029?lang=&edition=full","pubTime":"2021-01-01 10:23","market":"us","language":"zh","title":"华为平台全面下架腾讯游戏！","url":"https://stock-news.laohu8.com/highlight/detail?id=1176920029","media":"老虎资讯综合","summary":"1日讯，华为游戏中心社区发布公告：因腾讯游戏于2020年12月31日17点57分单方面就双方合作做出重大变更，导致双方的继续合作产生重大障碍，经过我司法务谨慎评估，我们不得不依照腾讯单方面要求暂停相关","content":"<p>1日讯，华为游戏中心社区发布公告：因腾讯游戏于2020年12月31日17点57分单方面就双方合作做出重大变更，导致双方的继续合作产生重大障碍，经过我司法务谨慎评估，我们不得不依照腾讯单方面要求暂停相关合作，将腾讯游戏从华为平台下架。</p><p><img src=\"https://static.tigerbbs.com/11ce88109a0a947e895dab4a91f4905d\" tg-width=\"474\" tg-height=\"576\"></p><p>腾讯游戏方面回应称，因华为手机游戏平台与我们的《手机游戏推广项目协议》未能如期续约，导致今天凌晨腾讯游戏的相关产品被突然下架。目前我们正积极与华为手机游戏平台沟通协商，争取尽快恢复。给各位用户带来的不便，我们深表歉意。</p><p>据第一财经报道，一知情人士表示，<b>事件的导火索在于分成比例没有谈拢</b>。</p><p>过去，游戏行业一直处于粗放发展的时期，也是渠道为王的时期。手机官方应用商店组成的硬核联盟，和游戏发行商分成比例一直是五五。而在国外，苹果App Store和安卓Google Play和发行商的分成比例是三七。</p><p>但随着市场环境的变化，用户触达游戏的渠道呈多元化趋势。传统货架式游戏分发渠道已经逐渐式微，年轻一代玩家逐渐通过游戏社区论坛、公众号、图文内容平台或周边口碑转播等接触和认知一款游戏，货架式游戏应用中心不再是玩家下载游戏的唯一通道，渠道也在变革的过程中。</p><p>从2019年年中开始，腾讯对渠道商提出了新的分成比例，旗下新游戏的流水渠道和开发以三七比例来分成，即应用市场拿三成，开发商等拿七成。</p><p>&nbsp;一不愿具名的手机厂商内部人士表示，腾讯方面就分成的问题这两年一直在与厂商进行谈判，但目前中国渠道市场较海外更加复杂，不能简单的说成是分成比例问题，也不能照搬海外分成模式。</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>华为平台全面下架腾讯游戏！</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n华为平台全面下架腾讯游戏！\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2021-01-01 10:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>1日讯，华为游戏中心社区发布公告：因腾讯游戏于2020年12月31日17点57分单方面就双方合作做出重大变更，导致双方的继续合作产生重大障碍，经过我司法务谨慎评估，我们不得不依照腾讯单方面要求暂停相关合作，将腾讯游戏从华为平台下架。</p><p><img src=\"https://static.tigerbbs.com/11ce88109a0a947e895dab4a91f4905d\" tg-width=\"474\" tg-height=\"576\"></p><p>腾讯游戏方面回应称，因华为手机游戏平台与我们的《手机游戏推广项目协议》未能如期续约，导致今天凌晨腾讯游戏的相关产品被突然下架。目前我们正积极与华为手机游戏平台沟通协商，争取尽快恢复。给各位用户带来的不便，我们深表歉意。</p><p>据第一财经报道，一知情人士表示，<b>事件的导火索在于分成比例没有谈拢</b>。</p><p>过去，游戏行业一直处于粗放发展的时期，也是渠道为王的时期。手机官方应用商店组成的硬核联盟，和游戏发行商分成比例一直是五五。而在国外，苹果App Store和安卓Google Play和发行商的分成比例是三七。</p><p>但随着市场环境的变化，用户触达游戏的渠道呈多元化趋势。传统货架式游戏分发渠道已经逐渐式微，年轻一代玩家逐渐通过游戏社区论坛、公众号、图文内容平台或周边口碑转播等接触和认知一款游戏，货架式游戏应用中心不再是玩家下载游戏的唯一通道，渠道也在变革的过程中。</p><p>从2019年年中开始，腾讯对渠道商提出了新的分成比例，旗下新游戏的流水渠道和开发以三七比例来分成，即应用市场拿三成，开发商等拿七成。</p><p>&nbsp;一不愿具名的手机厂商内部人士表示，腾讯方面就分成的问题这两年一直在与厂商进行谈判，但目前中国渠道市场较海外更加复杂，不能简单的说成是分成比例问题，也不能照搬海外分成模式。</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/ce88d7c500914d5edde5f4ccbc6959f5","relate_stocks":{"00700":"腾讯控股"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1176920029","content_text":"1日讯，华为游戏中心社区发布公告：因腾讯游戏于2020年12月31日17点57分单方面就双方合作做出重大变更，导致双方的继续合作产生重大障碍，经过我司法务谨慎评估，我们不得不依照腾讯单方面要求暂停相关合作，将腾讯游戏从华为平台下架。腾讯游戏方面回应称，因华为手机游戏平台与我们的《手机游戏推广项目协议》未能如期续约，导致今天凌晨腾讯游戏的相关产品被突然下架。目前我们正积极与华为手机游戏平台沟通协商，争取尽快恢复。给各位用户带来的不便，我们深表歉意。据第一财经报道，一知情人士表示，事件的导火索在于分成比例没有谈拢。过去，游戏行业一直处于粗放发展的时期，也是渠道为王的时期。手机官方应用商店组成的硬核联盟，和游戏发行商分成比例一直是五五。而在国外，苹果App Store和安卓Google Play和发行商的分成比例是三七。但随着市场环境的变化，用户触达游戏的渠道呈多元化趋势。传统货架式游戏分发渠道已经逐渐式微，年轻一代玩家逐渐通过游戏社区论坛、公众号、图文内容平台或周边口碑转播等接触和认知一款游戏，货架式游戏应用中心不再是玩家下载游戏的唯一通道，渠道也在变革的过程中。从2019年年中开始，腾讯对渠道商提出了新的分成比例，旗下新游戏的流水渠道和开发以三七比例来分成，即应用市场拿三成，开发商等拿七成。 一不愿具名的手机厂商内部人士表示，腾讯方面就分成的问题这两年一直在与厂商进行谈判，但目前中国渠道市场较海外更加复杂，不能简单的说成是分成比例问题，也不能照搬海外分成模式。","news_type":1},"isVote":1,"tweetType":1,"viewCount":1196,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":385259518,"gmtCreate":1613557222334,"gmtModify":1613557222334,"author":{"id":"3489705817352597","authorId":"3489705817352597","name":"我斗神","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3489705817352597","authorIdStr":"3489705817352597"},"themes":[],"htmlText":"苏踏踏 听！TV58&nbsp; 是&nbsp;","listText":"苏踏踏 听！TV58&nbsp; 是&nbsp;","text":"苏踏踏 听！TV58 是","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/385259518","repostId":"2112882414","repostType":2,"repost":{"id":"2112882414","pubTimestamp":1613494980,"share":"https://www.laohu8.com/m/news/2112882414?lang=&edition=full","pubTime":"2021-02-17 01:03","market":"us","language":"zh","title":"DEADLINE: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against  Clover Health Investments, Corp. – CLOV, CLOVW, IPOC","url":"https://stock-news.laohu8.com/highlight/detail?id=2112882414","media":"GlobeNewswire","summary":"NEW YORK, Feb. 17, 2021  -- Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Clover Health Investments, Corp. f/k/a Social Capital Hedosophia Holdings Corp. III   who:  purchased or otherwise acquired publicly traded Clover securities between October 6, 2020 and February 4, 2021, inclusive ; and/or  purchased or otherwise acquired Clover securities pursuant or traceable to the registration statement and prospectus issued in connection with the December 2020 Merger of Clover and Social Capital III.If you wish to serve as lead plaintiff, you must move the Court before the April 6, 2021 DEADLINE. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.Zhang Investor Law represents investors worldwide. Attorney Advertising. Prior results do not guarantee similar outcomes.","content":"<html><body><p>NEW YORK, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of  Clover Health Investments, Corp. f/k/a <a href=\"https://laohu8.com/S/IPOC.U\">Social Capital Hedosophia Holdings Corp. III</a> (NASDAQ: CLOV, CLOVW) (NYSE: IPOC) who: (1) purchased or otherwise acquired publicly traded Clover securities between October 6, 2020 and February 4, 2021, inclusive (the “Class Period”); and/or (2) purchased or otherwise acquired Clover securities pursuant or traceable to the registration statement and prospectus issued in connection with the December 2020 Merger of Clover and Social Capital III.<br/></p>\n<p>To join the class action, go to http://zhanginvestorlaw.com/join-action-form/?slug=clover-health-investments-corp&amp;id=2582 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email info@zhanginvestorlaw.com for information on the class action.</p>\n<p>如果您想加入这个集体诉讼案，请在这里提交您的信息。http://zhanginvestorlaw.com/join-action-form/?slug=clover-health-investments-corp&amp;id=2582</p>\n<p>If you wish to serve as lead plaintiff, you must move the Court before the <strong>April 6, 2021 DEADLINE.</strong>   A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. </p>\n<p>According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that-    Clover’s was under active investigation by the Department of Justice for at least 12 issues ranging from kickbacks to marketing practices to undisclosed third-party deals; the DOJ’s investigation presented an existential risk to the Company, since it derives most of its revenues from Medicare; Clover’s sales were driven by a major undisclosed related party deal and misleading marketing targeting the elderly, not its purported “best-in-class” technology; a significant portion of Clover sales were by way of an undisclosed relationship between Clover and an outside brokerage firm controlled by Clover’s Head of Sales; and as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.</p>\n<p>Lead plaintiff status is not required to seek compensation.  You may retain counsel of your choice.  You may remain an absent class member and take no action at this time.</p>\n<p>Zhang Investor Law represents investors worldwide. Attorney Advertising. Prior results do not guarantee similar outcomes.</p>\n<p>Zhang Investor Law P.C.<br/>99 Wall Street, Suite 232<br/>New York, New York 10005<br/>info@zhanginvestorlaw.com<br/>tel: (800) 991-3756<br/></p>\n<br/>\n<img height=\"1\" src=\"https://ml.globenewswire.com/release/track/397ce691-d08f-4fd4-bcbf-4dbc163b6780\" width=\"1\"/></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>DEADLINE: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against  Clover Health Investments, Corp. – CLOV, CLOVW, IPOC</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDEADLINE: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against  Clover Health Investments, Corp. – CLOV, CLOVW, IPOC\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-17 01:03 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/deadline-zhang-investor-law-alerts-170300583.html><strong>GlobeNewswire</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>NEW YORK, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of  Clover Health Investments, Corp. f/k/a Social Capital ...</p>\n\n<a href=\"https://finance.yahoo.com/news/deadline-zhang-investor-law-alerts-170300583.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://s.yimg.com/uu/api/res/1.2/9ZrC1RTINuwAePNbhMocgQ--~B/aD0xMjU7dz03NzU7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/vWhXIXoqEFvlQel1Gatm7Q--~B/aD0xMjU7dz03NzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/e259ec0cd2e22aa5c7cb38ac472d47ba","relate_stocks":{"CLOVW":"Clover Health Corp Warrant 2025/04/21 11.5C","CLOV":"Clover Health Corp"},"source_url":"https://finance.yahoo.com/news/deadline-zhang-investor-law-alerts-170300583.html","is_english":false,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2112882414","content_text":"NEW YORK, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of  Clover Health Investments, Corp. f/k/a Social Capital Hedosophia Holdings Corp. III (NASDAQ: CLOV, CLOVW) (NYSE: IPOC) who: (1) purchased or otherwise acquired publicly traded Clover securities between October 6, 2020 and February 4, 2021, inclusive (the “Class Period”); and/or (2) purchased or otherwise acquired Clover securities pursuant or traceable to the registration statement and prospectus issued in connection with the December 2020 Merger of Clover and Social Capital III.\nTo join the class action, go to http://zhanginvestorlaw.com/join-action-form/?slug=clover-health-investments-corp&id=2582 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email info@zhanginvestorlaw.com for information on the class action.\n如果您想加入这个集体诉讼案，请在这里提交您的信息。http://zhanginvestorlaw.com/join-action-form/?slug=clover-health-investments-corp&id=2582\nIf you wish to serve as lead plaintiff, you must move the Court before the April 6, 2021 DEADLINE.   A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. \nAccording to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that-    Clover’s was under active investigation by the Department of Justice for at least 12 issues ranging from kickbacks to marketing practices to undisclosed third-party deals; the DOJ’s investigation presented an existential risk to the Company, since it derives most of its revenues from Medicare; Clover’s sales were driven by a major undisclosed related party deal and misleading marketing targeting the elderly, not its purported “best-in-class” technology; a significant portion of Clover sales were by way of an undisclosed relationship between Clover and an outside brokerage firm controlled by Clover’s Head of Sales; and as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.\nLead plaintiff status is not required to seek compensation.  You may retain counsel of your choice.  You may remain an absent class member and take no action at this time.\nZhang Investor Law represents investors worldwide. Attorney Advertising. Prior results do not guarantee similar outcomes.\nZhang Investor Law P.C.99 Wall Street, Suite 232New York, New York 10005info@zhanginvestorlaw.comtel: (800) 991-3756","news_type":1},"isVote":1,"tweetType":1,"viewCount":1592,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":385259811,"gmtCreate":1613557169833,"gmtModify":1613557169833,"author":{"id":"3489705817352597","authorId":"3489705817352597","name":"我斗神","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3489705817352597","authorIdStr":"3489705817352597"},"themes":[],"htmlText":"84","listText":"84","text":"84","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/385259811","repostId":"2112882414","repostType":2,"repost":{"id":"2112882414","pubTimestamp":1613494980,"share":"https://www.laohu8.com/m/news/2112882414?lang=&edition=full","pubTime":"2021-02-17 01:03","market":"us","language":"zh","title":"DEADLINE: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against  Clover Health Investments, Corp. – CLOV, CLOVW, IPOC","url":"https://stock-news.laohu8.com/highlight/detail?id=2112882414","media":"GlobeNewswire","summary":"NEW YORK, Feb. 17, 2021  -- Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Clover Health Investments, Corp. f/k/a Social Capital Hedosophia Holdings Corp. III   who:  purchased or otherwise acquired publicly traded Clover securities between October 6, 2020 and February 4, 2021, inclusive ; and/or  purchased or otherwise acquired Clover securities pursuant or traceable to the registration statement and prospectus issued in connection with the December 2020 Merger of Clover and Social Capital III.If you wish to serve as lead plaintiff, you must move the Court before the April 6, 2021 DEADLINE. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.Zhang Investor Law represents investors worldwide. Attorney Advertising. Prior results do not guarantee similar outcomes.","content":"<html><body><p>NEW YORK, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of  Clover Health Investments, Corp. f/k/a <a href=\"https://laohu8.com/S/IPOC.U\">Social Capital Hedosophia Holdings Corp. III</a> (NASDAQ: CLOV, CLOVW) (NYSE: IPOC) who: (1) purchased or otherwise acquired publicly traded Clover securities between October 6, 2020 and February 4, 2021, inclusive (the “Class Period”); and/or (2) purchased or otherwise acquired Clover securities pursuant or traceable to the registration statement and prospectus issued in connection with the December 2020 Merger of Clover and Social Capital III.<br/></p>\n<p>To join the class action, go to http://zhanginvestorlaw.com/join-action-form/?slug=clover-health-investments-corp&amp;id=2582 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email info@zhanginvestorlaw.com for information on the class action.</p>\n<p>如果您想加入这个集体诉讼案，请在这里提交您的信息。http://zhanginvestorlaw.com/join-action-form/?slug=clover-health-investments-corp&amp;id=2582</p>\n<p>If you wish to serve as lead plaintiff, you must move the Court before the <strong>April 6, 2021 DEADLINE.</strong>   A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. </p>\n<p>According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that-    Clover’s was under active investigation by the Department of Justice for at least 12 issues ranging from kickbacks to marketing practices to undisclosed third-party deals; the DOJ’s investigation presented an existential risk to the Company, since it derives most of its revenues from Medicare; Clover’s sales were driven by a major undisclosed related party deal and misleading marketing targeting the elderly, not its purported “best-in-class” technology; a significant portion of Clover sales were by way of an undisclosed relationship between Clover and an outside brokerage firm controlled by Clover’s Head of Sales; and as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.</p>\n<p>Lead plaintiff status is not required to seek compensation.  You may retain counsel of your choice.  You may remain an absent class member and take no action at this time.</p>\n<p>Zhang Investor Law represents investors worldwide. Attorney Advertising. Prior results do not guarantee similar outcomes.</p>\n<p>Zhang Investor Law P.C.<br/>99 Wall Street, Suite 232<br/>New York, New York 10005<br/>info@zhanginvestorlaw.com<br/>tel: (800) 991-3756<br/></p>\n<br/>\n<img height=\"1\" src=\"https://ml.globenewswire.com/release/track/397ce691-d08f-4fd4-bcbf-4dbc163b6780\" width=\"1\"/></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>DEADLINE: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against  Clover Health Investments, Corp. – CLOV, CLOVW, IPOC</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDEADLINE: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against  Clover Health Investments, Corp. – CLOV, CLOVW, IPOC\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-17 01:03 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/deadline-zhang-investor-law-alerts-170300583.html><strong>GlobeNewswire</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>NEW YORK, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of  Clover Health Investments, Corp. f/k/a Social Capital ...</p>\n\n<a href=\"https://finance.yahoo.com/news/deadline-zhang-investor-law-alerts-170300583.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://s.yimg.com/uu/api/res/1.2/9ZrC1RTINuwAePNbhMocgQ--~B/aD0xMjU7dz03NzU7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/vWhXIXoqEFvlQel1Gatm7Q--~B/aD0xMjU7dz03NzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/e259ec0cd2e22aa5c7cb38ac472d47ba","relate_stocks":{"CLOVW":"Clover Health Corp Warrant 2025/04/21 11.5C","CLOV":"Clover Health Corp"},"source_url":"https://finance.yahoo.com/news/deadline-zhang-investor-law-alerts-170300583.html","is_english":false,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2112882414","content_text":"NEW YORK, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of  Clover Health Investments, Corp. f/k/a Social Capital Hedosophia Holdings Corp. III (NASDAQ: CLOV, CLOVW) (NYSE: IPOC) who: (1) purchased or otherwise acquired publicly traded Clover securities between October 6, 2020 and February 4, 2021, inclusive (the “Class Period”); and/or (2) purchased or otherwise acquired Clover securities pursuant or traceable to the registration statement and prospectus issued in connection with the December 2020 Merger of Clover and Social Capital III.\nTo join the class action, go to http://zhanginvestorlaw.com/join-action-form/?slug=clover-health-investments-corp&id=2582 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email info@zhanginvestorlaw.com for information on the class action.\n如果您想加入这个集体诉讼案，请在这里提交您的信息。http://zhanginvestorlaw.com/join-action-form/?slug=clover-health-investments-corp&id=2582\nIf you wish to serve as lead plaintiff, you must move the Court before the April 6, 2021 DEADLINE.   A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. \nAccording to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that-    Clover’s was under active investigation by the Department of Justice for at least 12 issues ranging from kickbacks to marketing practices to undisclosed third-party deals; the DOJ’s investigation presented an existential risk to the Company, since it derives most of its revenues from Medicare; Clover’s sales were driven by a major undisclosed related party deal and misleading marketing targeting the elderly, not its purported “best-in-class” technology; a significant portion of Clover sales were by way of an undisclosed relationship between Clover and an outside brokerage firm controlled by Clover’s Head of Sales; and as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.\nLead plaintiff status is not required to seek compensation.  You may retain counsel of your choice.  You may remain an absent class member and take no action at this time.\nZhang Investor Law represents investors worldwide. Attorney Advertising. Prior results do not guarantee similar outcomes.\nZhang Investor Law P.C.99 Wall Street, Suite 232New York, New York 10005info@zhanginvestorlaw.comtel: (800) 991-3756","news_type":1},"isVote":1,"tweetType":1,"viewCount":418,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":937051413,"gmtCreate":1574671030632,"gmtModify":1704728233941,"author":{"id":"3489705817352597","authorId":"3489705817352597","name":"我斗神","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3489705817352597","authorIdStr":"3489705817352597"},"themes":[],"htmlText":"中了一手","listText":"中了一手","text":"中了一手","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/937051413","repostId":"1160045784","repostType":4,"repost":{"id":"1160045784","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1574641000,"share":"https://www.laohu8.com/m/news/1160045784?lang=&edition=full","pubTime":"2019-11-25 08:16","market":"us","language":"zh","title":"阿里巴巴：香港IPO面向散户部分获得42.4倍认购","url":"https://stock-news.laohu8.com/highlight/detail?id=1160045784","media":"老虎资讯综合","summary":"据港媒报道，阿里巴巴（$(09988)$）成为港股史上集资额第三大新股。阿里昨天公布，以每股176元定价，较周二（19日）阿里ADS（美国存託股票）收市价折让2.8%，集资880亿元；在悉数行使超额配","content":"<p><img src=\"https://static.tigerbbs.com/626ae71536f62fb9c7fdbe50fbdbb2c7\">据港媒报道，阿里巴巴（<a href=\"https://laohu8.com/S/09988\">$(09988)$</a>）成为港股史上集资额第三大新股。阿里昨天公布，以每股176元定价，较周二（19日）阿里ADS（美国存託股票）收市价折让2.8%，集资880亿元；在悉数行使超额配售权后，总集资额将达1012亿元。据悉，阿里公开发售录得逾40倍超购，冻资约963亿元，问鼎今年新股冻资王。</p>\n<p><b>集资1012亿 史上第三重磅</b></p>\n<p>此外，港交所（<a href=\"https://laohu8.com/S/00388\">$(00388)$</a>）将推出阿里期货及期权，并批准发行商推出相关窝轮，与正股同于下周二挂牌，上市当日即纳入认可卖空指定证券名单。</p>\n<p>阿里原定发行5亿股，其中公开发售佔2.5%，国际配售佔97.5%，并设7500万股超额配售权，由瑞信及中金担任联席保荐人。由于公开发售超购逾40倍，将启动回拨机制，令公开发售股份佔比由2.5%增加至10%。据了解，国际配售部分获得主权基金及长仓基金等支持，亦录数倍超购。</p>\n<p>阿里表示，今次定价176元，是综合了ADS在周二收市价等因素釐定，相当于每份阿里ADS约180美元，较周二收市价185.25美元折让约2.8%，较公开发售价上限188元则低6.38%。路透报道，阿里已悉数行使超额配售权，集资额增至1012亿元，成为港股史上集资额第三大新股，仅次于2010年集资1590亿元的友邦（01299），以及2006年集资1249.5亿元的工行（01398），是9年来本港最大型IPO。阿里ADS收报182.35美元，跌1.57%。</p>\n<p><b>较ADS折让2.8% 反应胜预期</b></p>\n<p>辉立证券企业融资经理陈英杰表示，最终定价较阿里ADS有2.8%折让，亦低于公开发售价上限188元，加上公开发售反应热烈，超购远胜他预期的约10倍，算是意外惊喜；阿里下周二挂牌前，阿里ADS仍然有潜在下跌风险，挂牌当日有可能出现跟跌。不过，该行客户大部分表明会长揸，相信影响不大。</p>\n<p>有基金经理笑言，本身认购阿里不多，长远亦看好内地电商发展，尽管有折扣也仅属锦上添花，他反而最关注阿里最终能否获纳入恒指成分股及「港股通」。</p>\n<p>恒指公司最快今年底才会公布恒指纳入同股不同权（W股）股份的咨询文件，并一并处理第二上市的W股纳入相关指数；至于阿里能否快速晋身恒生综合指数，则由于阿里是首只第二上市的W股，恒指公司正研究使用合适方法去厘定阿里的「市值」，届时方知是否符合要求。</p>\n<p>港交所日前指出，现时第二上市的不同投票权架构公司，暂不纳入「港股通」股票范围，意味阿里短期内与北水无缘。</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>阿里巴巴：香港IPO面向散户部分获得42.4倍认购</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n阿里巴巴：香港IPO面向散户部分获得42.4倍认购\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2019-11-25 08:16</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><img src=\"https://static.tigerbbs.com/626ae71536f62fb9c7fdbe50fbdbb2c7\">据港媒报道，阿里巴巴（<a href=\"https://laohu8.com/S/09988\">$(09988)$</a>）成为港股史上集资额第三大新股。阿里昨天公布，以每股176元定价，较周二（19日）阿里ADS（美国存託股票）收市价折让2.8%，集资880亿元；在悉数行使超额配售权后，总集资额将达1012亿元。据悉，阿里公开发售录得逾40倍超购，冻资约963亿元，问鼎今年新股冻资王。</p>\n<p><b>集资1012亿 史上第三重磅</b></p>\n<p>此外，港交所（<a href=\"https://laohu8.com/S/00388\">$(00388)$</a>）将推出阿里期货及期权，并批准发行商推出相关窝轮，与正股同于下周二挂牌，上市当日即纳入认可卖空指定证券名单。</p>\n<p>阿里原定发行5亿股，其中公开发售佔2.5%，国际配售佔97.5%，并设7500万股超额配售权，由瑞信及中金担任联席保荐人。由于公开发售超购逾40倍，将启动回拨机制，令公开发售股份佔比由2.5%增加至10%。据了解，国际配售部分获得主权基金及长仓基金等支持，亦录数倍超购。</p>\n<p>阿里表示，今次定价176元，是综合了ADS在周二收市价等因素釐定，相当于每份阿里ADS约180美元，较周二收市价185.25美元折让约2.8%，较公开发售价上限188元则低6.38%。路透报道，阿里已悉数行使超额配售权，集资额增至1012亿元，成为港股史上集资额第三大新股，仅次于2010年集资1590亿元的友邦（01299），以及2006年集资1249.5亿元的工行（01398），是9年来本港最大型IPO。阿里ADS收报182.35美元，跌1.57%。</p>\n<p><b>较ADS折让2.8% 反应胜预期</b></p>\n<p>辉立证券企业融资经理陈英杰表示，最终定价较阿里ADS有2.8%折让，亦低于公开发售价上限188元，加上公开发售反应热烈，超购远胜他预期的约10倍，算是意外惊喜；阿里下周二挂牌前，阿里ADS仍然有潜在下跌风险，挂牌当日有可能出现跟跌。不过，该行客户大部分表明会长揸，相信影响不大。</p>\n<p>有基金经理笑言，本身认购阿里不多，长远亦看好内地电商发展，尽管有折扣也仅属锦上添花，他反而最关注阿里最终能否获纳入恒指成分股及「港股通」。</p>\n<p>恒指公司最快今年底才会公布恒指纳入同股不同权（W股）股份的咨询文件，并一并处理第二上市的W股纳入相关指数；至于阿里能否快速晋身恒生综合指数，则由于阿里是首只第二上市的W股，恒指公司正研究使用合适方法去厘定阿里的「市值」，届时方知是否符合要求。</p>\n<p>港交所日前指出，现时第二上市的不同投票权架构公司，暂不纳入「港股通」股票范围，意味阿里短期内与北水无缘。</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/f98a08f234fb3dfe04b5578614dea292","relate_stocks":{},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1160045784","content_text":"据港媒报道，阿里巴巴（$(09988)$）成为港股史上集资额第三大新股。阿里昨天公布，以每股176元定价，较周二（19日）阿里ADS（美国存託股票）收市价折让2.8%，集资880亿元；在悉数行使超额配售权后，总集资额将达1012亿元。据悉，阿里公开发售录得逾40倍超购，冻资约963亿元，问鼎今年新股冻资王。\n集资1012亿 史上第三重磅\n此外，港交所（$(00388)$）将推出阿里期货及期权，并批准发行商推出相关窝轮，与正股同于下周二挂牌，上市当日即纳入认可卖空指定证券名单。\n阿里原定发行5亿股，其中公开发售佔2.5%，国际配售佔97.5%，并设7500万股超额配售权，由瑞信及中金担任联席保荐人。由于公开发售超购逾40倍，将启动回拨机制，令公开发售股份佔比由2.5%增加至10%。据了解，国际配售部分获得主权基金及长仓基金等支持，亦录数倍超购。\n阿里表示，今次定价176元，是综合了ADS在周二收市价等因素釐定，相当于每份阿里ADS约180美元，较周二收市价185.25美元折让约2.8%，较公开发售价上限188元则低6.38%。路透报道，阿里已悉数行使超额配售权，集资额增至1012亿元，成为港股史上集资额第三大新股，仅次于2010年集资1590亿元的友邦（01299），以及2006年集资1249.5亿元的工行（01398），是9年来本港最大型IPO。阿里ADS收报182.35美元，跌1.57%。\n较ADS折让2.8% 反应胜预期\n辉立证券企业融资经理陈英杰表示，最终定价较阿里ADS有2.8%折让，亦低于公开发售价上限188元，加上公开发售反应热烈，超购远胜他预期的约10倍，算是意外惊喜；阿里下周二挂牌前，阿里ADS仍然有潜在下跌风险，挂牌当日有可能出现跟跌。不过，该行客户大部分表明会长揸，相信影响不大。\n有基金经理笑言，本身认购阿里不多，长远亦看好内地电商发展，尽管有折扣也仅属锦上添花，他反而最关注阿里最终能否获纳入恒指成分股及「港股通」。\n恒指公司最快今年底才会公布恒指纳入同股不同权（W股）股份的咨询文件，并一并处理第二上市的W股纳入相关指数；至于阿里能否快速晋身恒生综合指数，则由于阿里是首只第二上市的W股，恒指公司正研究使用合适方法去厘定阿里的「市值」，届时方知是否符合要求。\n港交所日前指出，现时第二上市的不同投票权架构公司，暂不纳入「港股通」股票范围，意味阿里短期内与北水无缘。","news_type":1},"isVote":1,"tweetType":1,"viewCount":1459,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}